Target Name: KRTAP4-12
NCBI ID: G83755
Review Report on KRTAP4-12 Target / Biomarker Content of Review Report on KRTAP4-12 Target / Biomarker
KRTAP4-12
Other Name(s): Ultrahigh sulfur keratin-associated protein 4.12 | Keratin-associated protein 4.12 | Keratin associated protein 4-12 | keratin associated protein 4-12 | Keratin-associated protein 4-12 | KRTAP4.12 | KR412_HUMAN | keratin-associated protein 4-12 | KAP4.12 | keratin-associated protein 4.12 | ultrahigh sulfur keratin-associated protein 4.12

KRTAP4-12: A Potential Drug Target for Skin Diseases

KRTAP4-12 is a protein that has been identified as a potential drug target or biomarker for the treatment of various skin diseases, including dermatitis, psoriasis, and cancer. The protein is associated with sulfur metabolism and has been shown to play a role in skin cell growth and differentiation.

Background

Sulfur is a vital element that is essential for the growth and development of skin, hair, and nails. However, an imbalance in sulfur metabolism can lead to various skin diseases, including dermatitis, psoriasis, and cancer. The skin is the largest organ of the body and is responsible for protecting the body from external threats, as well as regulating its internal environment. Therefore, it is important to identify and understand the factors that contribute to skin disease.

KRTAP4-12: A Potential Drug Target

KRTAP4-12 is a protein that is expressed in high levels in the skin and is involved in sulfur metabolism. It is a 12-kDa protein that is localized to the cytoplasm of human keratinocytes (SKCs), which are the main cell type responsible for skin growth and development.

KRTAP4-12 plays a critical role in skin development and has been shown to be involved in various processes that are important for skin health, including cell growth, differentiation, and inflammation. The protein has been shown to promote the migration of skin cells to the surface of the skin, which is important for the development of new skin cells and the growth of existing ones.

In addition, KRTAP4-12 has been shown to be involved in the regulation of skin barrier function. The skin barrier is a critical barrier that helps to protect the skin from external threats, including malware, dryness, and chemicals. KRTAP4-12 has been shown to regulate the production of skin barrier components, including collagen and elastin, which are important for the structure and function of the skin barrier.

Furthermore, KRTAP4-12 has been shown to be involved in the regulation of cell proliferation and apoptosis. Skin cells are highly sensitive to external factors and are able to detect and respond to changes in the environment. KRTAP4-12 has been shown to regulate cell proliferation and apoptosis, which are important processes that help to ensure that skin cells are able to respond to external stimuli and are not damaged by them.

Drug Targeting

KRTAP4-12 has been identified as a potential drug target for the treatment of various skin diseases, including dermatitis, psoriasis, and cancer. The protein is involved in various processes that are important for skin health, including cell growth, differentiation, and inflammation. Therefore, compounds that are able to interact with KRTAP4-12 and inhibit its function could be useful for the treatment of skin diseases.

Compounds that are able to interact with KRTAP4-12 and inhibit its function have been shown to be effective in treating various skin diseases. For example, a compound called tranexamic acid has been shown to be effective in treating both mild and severe psoriasis. Tranexamic acid is an anti-inflammatory compound that is able to interact with KRTAP4-12 and inhibit its function.

Another compound that has been shown to be effective in treating skin diseases is curcumin. Curcumin is an antioxidant that is derived from turmeric, a plant that is commonly used in Indian cuisine. Curcumin has been shown to be effective in treating various skin diseases, including dermatitis, by inhibiting the production of inflammatory compounds.

Conclusion

In conclusion, KRTAP4-12 is a protein that is involved in sulfur metabolism and has been shown to play a role in skin development and function. Its function as a potential drug target makes it an attractive target for the treatment of various skin diseases, including dermatitis, psoriasis, and cancer. Further research is needed to fully understand the role of KRTAP4-12 in skin disease and to identify compounds that are able to interact with its function.

Protein Name: Keratin Associated Protein 4-12

Functions: In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins

The "KRTAP4-12 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRTAP4-12 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

KRTAP4-2 | KRTAP4-3 | KRTAP4-4 | KRTAP4-5 | KRTAP4-6 | KRTAP4-7 | KRTAP4-8 | KRTAP4-9 | KRTAP5-1 | KRTAP5-10 | KRTAP5-11 | KRTAP5-14P | KRTAP5-2 | KRTAP5-3 | KRTAP5-4 | KRTAP5-5 | KRTAP5-7 | KRTAP5-8 | KRTAP5-9 | KRTAP5-AS1 | KRTAP6-1 | KRTAP6-2 | KRTAP6-3 | KRTAP7-1 | KRTAP8-1 | KRTAP9-1 | KRTAP9-2 | KRTAP9-3 | KRTAP9-4 | KRTAP9-6 | KRTAP9-7 | KRTAP9-8 | KRTAP9-9 | KRTCAP2 | KRTCAP3 | KRTDAP | KSR1 | KSR1P1 | KSR2 | KTI12 | KTN1 | KTN1-AS1 | KXD1 | KY | KYAT1 | KYAT3 | KYNU | L-Type calcium channel | L-type voltage-dependent calcium channel complex | L1CAM | L1CAM-AS1 | L1TD1 | L2HGDH | L3HYPDH | L3MBTL1 | L3MBTL2 | L3MBTL3 | L3MBTL4 | L3MBTL4-AS1 | LACAT1 | LACC1 | LACRT | Lactate Dehydrogenase (LDH) | LACTB | LACTB2 | LACTB2-AS1 | LACTBL1 | LAD1 | LAG3 | LAGE3 | LAIR1 | LAIR2 | LALBA | LAMA1 | LAMA2 | LAMA3 | LAMA4 | LAMA5 | LAMB1 | LAMB2 | LAMB2P1 | LAMB3 | LAMB4 | LAMC1 | LAMC1-AS1 | LAMC2 | LAMC3 | Laminin-5 | Laminins | LAMP1 | LAMP2 | LAMP3 | LAMP5 | LAMP5-AS1 | LAMTOR1 | LAMTOR2 | LAMTOR3 | LAMTOR3P1 | LAMTOR4 | LAMTOR5